Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • APH vs GSK✓SelectedUSD · GSKAPH vs GSK performance historyLatest closeAs of-1.75%11/13
Stock and ETF performance explorer

APH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+270.9%
GSK return
+65.8%
Excess return
+205.0%
Maximum drawdown
-28.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.7%+0.5%-2.3%-1.7%
7D+4.9%+1.1%+3.7%+5.0%
30D-5.4%+6.3%-11.7%-4.9%
3M-5.5%+1.8%-7.3%-5.1%
6M+25.9%+1.7%+24.3%+26.3%
YTD+16.4%+6.5%+9.8%+17.0%
1Y+16.5%+9.5%+7.0%+17.1%
3Y+270.9%+65.3%+205.5%+276.7%
All+270.9%+65.8%+205.0%+276.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling